More than 40 million people in the United States take
Statin Drugs every day. The purpose is to lower your LDL
(BAD) Cholesterol. Statin drugs along with penicillin, and
aspirin, may well be the three greatest drugs ever
developed. These cholesterol fighting drugs have been known
to lower your bad cholesterol by as much as 25% to 40%
depending upon your unique body chemistry, and the actual
dosage that you take.
Statin drugs are the most profitable drugs manufactured by
the major drug firms. The five principal drug companies and
their respective statin drugs are:
Name of Drug Company: Merck
Generic Name: Zocor
Brand Name: Simvastatin
Name of Drug Company: Merck
Generic Name: Mevacor
Brand Name: Lovastatin
Name of Drug Company: Pfizer
Generic Name: Lipitor
Brand Name: Atorvastatin
Name of Drug Company: AstraZeneca
Generic Name: Crestor
Brand Name: Rosuvstatin
Name of Drug Company: Kos Pharaceuticals
Generic Name: Advicor
Brand Name: Lovastatin
Research has shown that half the people in this country who
suffer heart attacks have NORMAL Cholesterol levels at the
time of their attack. That's right; half the heart attack
victims are NORMAL. This implies that your Total
Cholesterol level is not the MAGIC KEY that doctors are
looking for. We also know that if you drive your LDL (BAD)
Cholesterol level down to 60, heart disease seems to stop
dead in its tracks. LDL Cholesterol is a subset of your
Total Cholesterol. It is just one component of your
Cholesterol, but obviously a very important one.
Here's the Potential PROBLEM???
We know that all drugs have side effects. Manufacturers
attempt to measure and quantify these side effects during
the FDA approved clinical trials. These trials take place
prior to a drug's mass distribution to the public.
Sometimes, certain side effects do not become apparent
until years after the drug's release.
Dr. Ralph Edwards is the director of the drug-monitoring
center of the World Health Organization (WHO). He possesses
a data base containing 4 million people, the drugs they
take, and the side effects they report. He has found 172
people in that data base who developed Lou Gehrig's disease
or something similar. All 172 had been taking prescription
drugs. Of these, 40 had been taking statin drugs, which is
the subject of our discussion.
Statistically, no more than ten patients should have been
taking statin drugs and reported this type of result. It is
a statistically unexplainable event. In other words too
many people taking statin drugs are reporting the
development of Lou Gehrig's disease, or similar type
illnesses. We are not saying there is a direct correlation
between the use of the statin drug and the onset of these
crippling diseases. There is without question, cause for
immediate and further study.
In addition, if you are taking any of the statin drugs
listed in this article, and you are experiencing any type
of side effects at all, INFORM YOUR DOCTOR IMMEDIATELY.
Call him TODAY, not TOMMORROW.
Throughout the decades the major drug companies have
attempted to downplay drug side effects. This explains the
FDA's policy for decades of keeping drug side effects
quiet. They were not published in the media. The World
Health Organization is under no such requirement. Over the
last couple of years, the FDA in response to public demand
has published their drug findings on the Internet on a
quarterly basis.
PATIENT BEWARE
Most of us were taught the term caveat emptor, which means
BUYER BEWARE. We now must use the term PATIENT BEWARE. We
have a responsibility to our loved ones, and ourselves to
be aware of the adverse effects of the drugs we are using.
In the 21st century, we are in a period of information
overload. There is simply too much information coming at
all of us to digest. This includes doctors. We as patients
can not be completely reliant on our doctors being 100%
knowledgeable about the adverse events that can be produced
by the drugs their patients are taking. You must be
informed yourself. For a more elaborate version of this
article, please see our website.
Goodbye and Good Luck
----------------------------------------------------
Richard Stoyeck's background includes being a limited
partner at Bear Stearns, Senior VP at Lehman Brothers, Kuhn
Loeb, Arthur Andersen, and KPMG. Educated at Pace
University, NYU, and Harvard University, today he runs
Rockefeller Capital Partners and StocksAtBottom.com
http://www.stocksatbottom.com/ez.html
No comments:
Post a Comment